ArticleTranslational oncology2024

CuET overcomes regorafenib resistance by inhibiting epithelial-mesenchymal transition through suppression of the ERK pathway in hepatocellular carcinoma.

Ding Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.